Moderna Inc. rose as much as 6.6% Friday afternoon and Novavax Inc. rose as much as 7.8%. American depositary receipts of BioNTech SE, Pfizer Inc.’s Covid vaccine partner, climbed as much as 5.1%.

An image that is spreading widely online claims that Moderna had created its COVID-19 vaccine two years before the pandemic ...

In the dark days of the coronavirus pandemic, Moderna (NASDAQ: MRNA) was a ray of light in more ways than one. The healthcare ...

Snopes tried to discredit research as a "rumor" when journalist received early results from conference call between researchers and study participants. Spike still detectable in some participants ...

Bloomberg News Now is a comprehensive audio report on today's top stories. Listen for the latest news, whenever you want it, covering global business stories around the world.

Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...

CoV-2, has been discovered in China and is “strikingly similar to the pandemic virus” and feared to be powerful ...

While the details surrounding the new virus are still unfolding, the market's reaction reflects concern over the potential ...

Moderna Inc. (NASDAQ:MRNA) reported a fourth-quarter EPS loss of $(2.91), missing the consensus of $(2.62), a turnaround from ...

An epidemiologist said the Franklin County resolution was "based on conspiracy and misinformation against the COVID-19 ...

Moderna has been ordered to pay almost £44,000 after 12-year-olds were encouraged to join Covid vaccine trials with the ...

The biopharma reported disappointing fourth-quarter results, missing bottom line estimates amid a steep decline in COVID-19 ...